EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY 4.0

Efficacy and Safety of Generic Fluocinolone Acetonide, Hydroquinone, and Tretinoin Cream Compared With TRI‐LUMA for the Treatment of Moderate‐To‐Severe Melasma in Chinese Patients: A Randomized, Single‐Center, Placebo‐Controlled Trial

Honghua Hu iD, Pengfei Zhou, Hongliang Yao, Chengyao Zhu iD, Bo Shen, Bo Feng, Xiangke Yu, Lunfei Liu

Journal of Cosmetic Dermatology · 2025

DOI: 10.1111/jocd.70205 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Honghua Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Me…. Hauptthemen laut MEDLINE: Melanosis, Fluocinolone Acetonide, Tretinoin, Hydroquinones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Fund of Zhejiang Provincial Education Department, Zhejiang Fonow Medicine Co. Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Treatment with fluocinolone acetonide, hydroquinone, and tretinoin cream is the gold standard for melasma; however, the effects of this treatment in the Chinese population remain unclear. Due to the differences between Chinese and Caucasian subjects, further clinical trials in Chinese patients with melasma are needed.

Aim

To evaluate the efficacy and safety of fluocinolone acetonide, hydroquinone, and tretinoin creams in Chinese patients with moderate‐to‐severe melasma.

Methods

We recruited 53 patients who received a generic formulation (triple combination cream, TCC), brand formulation (TRI‐LUMA), or placebo once daily for 8 weeks. In weeks 4 and 8, efficacy was evaluated based on the Melasma Severity Scale and Melasma Area and Severity Index. In addition, safety was assessed based on the incidence and severity of treatment‐emergent adverse events.

Results

The generic TCC group achieved 52.2% efficacy compared to 57.1% in the TRI‐LUMA group. There was no significant difference in the incidence of adverse effects between the TCC and TRI‐LUMA groups (69.6% and 90.5%, respectively; p > 0.05). The incidence of adverse events in the placebo group was 0%.

Conclusion

Generic TCC was as effective as TRI‐LUMA and had a similar safety profile in this study of Chinese subjects with moderate‐to‐severe melasma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanosisFluocinolone AcetonideTretinoinHydroquinonesDrugs, GenericDermatologic AgentsHumansFemaleAdultMaleSeverity of Illness IndexTreatment OutcomeMiddle AgedDrug CombinationsYoung AdultSkin CreamChinaDouble-Blind MethodAdministration, CutaneousEast Asian People

Stichwörter der Autor:innen

efficacyfluocinolone acetonide, hydroquinone, and tretinoin creammelasmasafety

Substanzen

Fluocinolone AcetonideTretinoinhydroquinoneHydroquinonesDrugs, GenericDrug CombinationsDermatologic Agents

Autor:innen und Institutionen

  • Department of Dermatology, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.
  • Department of Dermatology, Linping Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, China.

ORCID-Profile: Honghua Hu, Chengyao Zhu

Förderung

  • Scientific Research Fund of Zhejiang Provincial Education Department
  • Zhejiang Fonow Medicine Co. Ltd

Zitieren

APA

Hu, H., Zhou, P., Yao, H., Zhu, C., Shen, B., Feng, B., Yu, X., & Liu, L. (2025). Efficacy and Safety of Generic Fluocinolone Acetonide, Hydroquinone, and Tretinoin Cream Compared With TRI‐LUMA for the Treatment of Moderate‐To‐Severe Melasma in Chinese Patients: A Randomized, Single‐Center, Placebo‐Controlled Trial. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70205

Vancouver

Hu H, Zhou P, Yao H, Zhu C, Shen B, Feng B, et al. Efficacy and Safety of Generic Fluocinolone Acetonide, Hydroquinone, and Tretinoin Cream Compared With TRI‐LUMA for the Treatment of Moderate‐To‐Severe Melasma in Chinese Patients: A Randomized, Single‐Center, Placebo‐Controlled Trial. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70205

BibTeX
@article{Hu2025,
  author = {Hu, Honghua and Zhou, Pengfei and Yao, Hongliang and Zhu, Chengyao and Shen, Bo and Feng, Bo and Yu, Xiangke and Liu, Lunfei},
  title = {Efficacy and Safety of Generic Fluocinolone Acetonide, Hydroquinone, and Tretinoin Cream Compared With TRI‐LUMA for the Treatment of Moderate‐To‐Severe Melasma in Chinese Patients: A Randomized, Single‐Center, Placebo‐Controlled Trial},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  doi = {10.1111/jocd.70205}
}
Kostenlos starten →